Follow-The-Filings

Security

BIO

Bio Rad Labs Inc. · CL A

Equity holders as of 2026 Q1 (each manager’s latest book)

15 owners 1 new max 2.5% (John Rogers - Ariel Inves...)

grid → activity →
owners 15
max % 2.5%
tracked value $1.9B
qoq N 1 A 8 R 4

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
John Rogers - Ariel Investments, LLC 2026 Q1 2.5% Add -0.05 pp 785,961 $219M hist
Mason Hawkins - Southeastern Asset Management INC/TN/ 2026 Q1 2.2% Reduce -0.84 pp 162,804 $45M hist
First Pacific Advisors, LP 2026 Q1 1.6% Add -0.01 pp 407,358 $114M hist
First Eagle Investment Management, LLC 2026 Q1 1.0% — 2,602,772 $726M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.1% Add 0.00 pp 152,384 $42M hist
Natixis Advisors, LLC 2026 Q1 0.0% Add 0.00 pp 75,047 $21M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 1,774,263 $538M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add +0.01 pp 148,669 $41M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Reduce 0.00 pp 118,683 $33M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add +0.01 pp 94,549 $26M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add +0.01 pp 33,217 $9M hist
Norges Bank 2025 Q4 stale 0.0% Exit 0.00 pp 114,194 $35M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Add 0.00 pp 8,145 $2M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 3,294 $918 hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.0% New 0.0% 1,684 $469 hist

15 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.67B $2.57B $2.58B
Gross profit $362.4M $325.9M $1.34B
Gross margin * 13.6% 12.7% 51.9%
Net income $69M $383.9M $759.9M
Net margin * 2.6% 15.0% 29.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.05B $3.03B $2.91B
Total non-current assets * $9.25B $6.33B $7.67B
Total assets $12.3B $9.36B $10.58B
Total current liabilities $522.8M $467.8M $517M
Total non-current liabilities * $3.04B $2.33B $2.61B
Total equity $8.74B $6.57B $7.45B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $374.94M $455.2M $532.2M
Cash from investing $20.21M -$160.2M -$189.7M
Cash from financing -$425.65M -$218.8M -$283.2M
Net change in cash -$30.18M $85.4M $42.4M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders